Free Newsletter
Alli hits Europe, beefing up GSK's consumer line
Free newsletter via e-mail
Tools
GlaxoSmithKline launched its nonprescription weight-loss drug alli in European pharmacies, boosting its line-up of consumer products in the region. Glaxo is eyeing its OTC meds for growth at a time when prescription drug sales are slowing down. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: